NASDAQ · Financial Statements
Cytocom, Inc. (CBLI) Financial Statements
$3.17
NASDAQ: CBLI
Market Cap $226.39M
Overview Financials Dividend Cytocom, Inc. most recently reported annual revenue of $0, a net loss of $2.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2016 2017 2018 2019 2020 Revenue $4.0M $2.0M $1.0M $1.0M $0 Operating Profit $-6.0M $-6.0M $-5.0M $-2.0M $-3.0M Net Profit $-3.0M $-10.0M $-4.0M $-3.0M $-2.0M EPS $-0.24 $-0.87 $-0.32 $-0.23 $-0.19 Op Margin -180.7% -287.5% -421.7% -212.0% -983.7%
Balance Sheet (USD)
Metric 2016 2017 2018 2019 2020 Total Assets $16.0M $10.0M $5.0M $2.0M $2.0M Total Liabilities $3.0M $2.0M $1.0M $1.0M $0 Cash $7.0M $4.0M $4.0M $1.0M $2.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2016 2017 2018 2019 2020 Operating Cash Flow $-5.0M $-7.0M $-5.0M $-3.0M $-2.0M Investing Cash Flow $6.0M $4.0M $4.0M $0 $0 Financing Cash Flow $1.0M $0 $0 $0 $3.0M Net Cash Flow $1.0M $-3.0M $-1.0M $-2.0M $1.0M Free Cash Flow $-5.0M $-7.0M $-5.0M $-3.0M $-2.0M
Valuation & Return Ratios
Metric Value PEG Ratio 2.31 EV / EBITDA -94.03 FCF Yield -1.05% Quick Ratio 7.60 Interest Coverage — Return 1Y — Return 3Y — Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .